Yue‐Ping Liu

2.1k total citations
77 papers, 1.4k citations indexed

About

Yue‐Ping Liu is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yue‐Ping Liu has authored 77 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 33 papers in Oncology and 29 papers in Pathology and Forensic Medicine. Recurrent topics in Yue‐Ping Liu's work include Lymphoma Diagnosis and Treatment (17 papers), Breast Cancer Treatment Studies (15 papers) and Advanced Radiotherapy Techniques (14 papers). Yue‐Ping Liu is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Breast Cancer Treatment Studies (15 papers) and Advanced Radiotherapy Techniques (14 papers). Yue‐Ping Liu collaborates with scholars based in China, United States and Ethiopia. Yue‐Ping Liu's co-authors include Ye‐Xiong Li, Shulian Wang, Weihu Wang, Jing Jin, Yong-Wen Song, Zihao Yu, Xin-Fan Liu, Hui Fang, Liqiang Zhou and Hua Ren and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yue‐Ping Liu

71 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yue‐Ping Liu China 19 736 705 366 221 208 77 1.4k
Dongryul Oh South Korea 25 753 1.0× 213 0.3× 849 2.3× 704 3.2× 102 0.5× 150 2.0k
Amy A. Kirkwood United Kingdom 24 959 1.3× 693 1.0× 169 0.5× 242 1.1× 62 0.3× 85 2.0k
Dominic Culligan United Kingdom 26 767 1.0× 929 1.3× 224 0.6× 403 1.8× 586 2.8× 75 2.9k
James Biagi Canada 22 1.2k 1.6× 376 0.5× 503 1.4× 494 2.2× 63 0.3× 61 1.9k
Graziella Pinotti Italy 20 986 1.3× 956 1.4× 282 0.8× 517 2.3× 163 0.8× 62 2.0k
Elizabeth Tracey Australia 24 798 1.1× 293 0.4× 430 1.2× 360 1.6× 39 0.2× 54 1.9k
Mathew H. Chung United States 23 751 1.0× 186 0.3× 883 2.4× 414 1.9× 72 0.3× 74 1.8k
Giovanni Franchin Italy 25 646 0.9× 152 0.2× 531 1.5× 852 3.9× 113 0.5× 109 2.0k
Sharon S. Lum United States 22 637 0.9× 276 0.4× 392 1.1× 301 1.4× 109 0.5× 102 1.4k
F R Appelbaum United States 25 876 1.2× 408 0.6× 142 0.4× 242 1.1× 655 3.1× 47 3.0k

Countries citing papers authored by Yue‐Ping Liu

Since Specialization
Citations

This map shows the geographic impact of Yue‐Ping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue‐Ping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue‐Ping Liu more than expected).

Fields of papers citing papers by Yue‐Ping Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue‐Ping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue‐Ping Liu. The network helps show where Yue‐Ping Liu may publish in the future.

Co-authorship network of co-authors of Yue‐Ping Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yue‐Ping Liu. A scholar is included among the top collaborators of Yue‐Ping Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue‐Ping Liu. Yue‐Ping Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wei, Hui Fang, Jing Hao, et al.. (2025). Depression and anxiety in patients with breast cancer receiving radiotherapy: a longitudinal study. Therapeutic Advances in Medical Oncology. 17. 22790666–22790666.
2.
Ma, Huiying, Yuan Tang, Haitao Zhou, et al.. (2024). Results of a prospective phase II study of total neoadjuvant therapy for locally advanced rectal cancer.. Journal of Clinical Oncology. 42(3_suppl). 147–147.
3.
Liu, Zhiqiang, Siye Chen, Yong-Wen Song, et al.. (2023). Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II Study. Technology in Cancer Research & Treatment. 22. 2223915661–2223915661. 1 indexed citations
4.
Tian, Yuan, Yong-Wen Song, Shulian Wang, et al.. (2023). Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac. Frontiers in Oncology. 13. 1039901–1039901. 6 indexed citations
5.
Liu, Xin, Yong Yang, Shulian Wang, et al.. (2022). Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy. Journal of Cancer Research and Clinical Oncology. 149(8). 5219–5230. 2 indexed citations
6.
7.
Chen, Bo, Jianxiong Wu, Liming Wang, et al.. (2021). Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC. Hepatology. 74(5). 2595–2604. 48 indexed citations
8.
9.
10.
11.
Yao, Lihong, Jianzhong Shou, Shulian Wang, et al.. (2020). Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis. Radiation Oncology. 15(1). 231–231. 4 indexed citations
12.
Liu, Yue‐Ping, Liansheng Zhang, Fang Hao, et al.. (2016). An analysis of interfractional and intrafractional prostate motion in hypofractionated precise radiotherapy for prostate cancer. Zhonghua fangshe zhongliuxue zazhi. 25(11). 1199–1203.
13.
Liu, Li, et al.. (2016). Use of a knowledge-attitude-behaviour education programme for Chinese adults undergoing maintenance haemodialysis: Randomized controlled trial. Journal of International Medical Research. 44(3). 557–568. 74 indexed citations
14.
Wang, Weihu, Zhi Wang, Jianxiong Wu, et al.. (2015). Survival benefit with IMRT following narrow‐margin hepatectomy in patients with hepatocellular carcinoma close to major vessels. Liver International. 35(12). 2603–2610. 51 indexed citations
15.
Feng, Yanru, Jing Jin, Xin Wang, et al.. (2014). Comparison of concurrent chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone in stage II/III rectal cancer patients after radical operation. Zhonghua fangshe zhongliuxue zazhi. 23(3). 199–204. 2 indexed citations
16.
Zhao, Ting, Ye‐Xiong Li, Shulian Wang, et al.. (2012). Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type. Annals of Hematology. 92(3). 325–332. 3 indexed citations
17.
Lu, Ning-Ning, Ye‐Xiong Li, Runye Wu, et al.. (2012). Dosimetric and Clinical Outcomes of Involved-Field Intensity-Modulated Radiotherapy After Chemotherapy for Early-Stage Hodgkin’s Lymphoma With Mediastinal Involvement. International Journal of Radiation Oncology*Biology*Physics. 84(1). 210–216. 23 indexed citations
18.
Qi, Shunan, Ye‐Xiong Li, Weihu Wang, et al.. (2011). The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvement. Leukemia & lymphoma. 53(5). 855–861. 8 indexed citations
19.
Li, Ye‐Xiong, Weihu Wang, Yong-Wen Song, et al.. (2009). Comparison of acute toxicities between two postoperative concurrent chemoradiotherapy regimens of capecitabine with or without oxaliplatin in patients with stage II and III rectal cancer. Zhonghua fangshe zhongliuxue zazhi. 18(3). 200–204. 2 indexed citations
20.
Liu, Yue‐Ping, Yunping Zhu, Yuan Qu, et al.. (2005). A new look at langerhans cell histiocytosis: Review of a series of 55 cases. Chinese Journal of Cancer Research. 17(2). 132–136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongryul Oh Breakdown of academic impact, for papers by Amy A. Kirkwood Breakdown of academic impact, for papers by Dominic Culligan Breakdown of academic impact, for papers by James Biagi Breakdown of academic impact, for papers by Graziella Pinotti Breakdown of academic impact, for papers by Elizabeth Tracey Breakdown of academic impact, for papers by Mathew H. Chung Breakdown of academic impact, for papers by Giovanni Franchin Breakdown of academic impact, for papers by Sharon S. Lum Breakdown of academic impact, for papers by F R Appelbaum
Rankless by CCL
2026